FDA Puts Import Alert on Shrimp From Most of Malaysia
The Food and Drug Administration on April 18 issued an import alert authorizing its district offices to hold all shipments of aquacultured shrimp and prawns from peninsular Malaysia (here). The alert follows FDA testing that showed an increase in already…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
high levels of animal drugs, with nearly one-third of sampled shipments testing positive, said FDA in a constituent update (here). FDA had been placing Malaysian companies individually on import alert. The alert does not apply to the Malaysian states of Sarawak and Sabah, and importers should provide documentation declaring the source farm if they bring in shrimp from one of these two states. If an importer finds its shipment has been held under the alert, the owner or consignee should provide the results of a private laboratory analysis showing a sample collected from the shipment does not contain any residues of nitrofuran or chloramphenicol. Malaysian companies may be placed on a “green list” of firms exempt from the import alert supporting its request to FDA, including whether it has appropriate controls and processes in place to prevent the appearance of future residues, said FDA.